Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

April 16, 2017 updated by: Paul G. Harch, M.D.
That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The study is a retrospective review of the PI's experience using SPECT brain imaging and hyperbaric oxygen therapy in the diagnosis and treatment of non-acute phases of carbon monoxide poisoning. The purpose is to see if the SPECT brain imaging is consistent with the clinical condition and cognitive testing on the patients.

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Louisiana
      • Marrero, Louisiana, United States, 70072
        • Recruiting
        • Family Physicians Center
        • Contact:
        • Principal Investigator:
          • Paul G Harch, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment. Retrospective chart review

Description

Inclusion Criteria:

  • Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment

Exclusion Criteria:

  • None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
HBOT
Drug: HBOT
total body exposure to greater than atmospheric pressure oxygen

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
SPECT brain imaging
Time Frame: after completion of HBOT
after completion of HBOT

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
clinical history and physical exam
Time Frame: after completion of HBOT
after completion of HBOT
Neuropsychological testing
Time Frame: After the final HBOT
Neuropsychological testing performed after the final HBOT in those who had neuropsychological testing before HBOT
After the final HBOT

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Paul G. Harch, M.D.

Collaborators

Harch Hyperbaric Research Foundation

Investigators

  • Principal Investigator: Paul G Harch, M.D., LSU School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2007

Primary Completion (Anticipated)

December 1, 2018

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

January 4, 2008

First Submitted That Met QC Criteria

January 4, 2008

First Posted (Estimate)

January 16, 2008

Study Record Updates

Last Update Posted (Actual)

April 18, 2017

Last Update Submitted That Met QC Criteria

April 16, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LSU IRB #6626

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuropsychiatric Sequelae of Carbon Monoxide Poisoning

Clinical Trials on HBOT

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe